相关实验视频

Updated: Jan 18, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

解开VEGF-ETS1轴:对子宫内膜异位症中血管生成的转录基因和单细胞分析

Xiaoxuan Liu^1,2,3,4,5, Ran An⁶, Ping Zhang^1,2,3,4,5

¹Department of Obstetrics and Gynecology, Shandong Provincial Hospital, Shandong University, Jinan, 250000, Shandong, China.

Journal of assisted reproduction and genetics

|January 16, 2026

概括

子宫内膜异位症涉及异常的血管生长. 研究人员发现,ETS1基因通过增强VEGF信号来驱动这个过程,确定了潜在的子宫内膜异位症治疗的关键途径.

科学领域:

妇科疾病妇科疾病
血管生物学血管生物学
转录法规转录法规

背景情况:

子宫内膜异位症 (EM) 是一种慢性炎症性疾病.
异常血管生成是EM病变的一个关键特征.
在EM中血管重塑的转录机制尚未完全理解.

研究的目的:

确定子宫内膜异位症发病过程中的关键转录调节体.
阐明这些调节剂在异常血管生成中的作用.
探索子宫内膜异位症的潜在治疗点.

主要方法:

大量和单细胞转录组数据的综合分析.
在子宫内膜异位症病变和验证队列中对ETS1的表达分析.
单细胞RNA测序以确定ETS1在内皮细胞中的表达.
功能丰富和伪时间分析以评估血管生成潜力.
研究病变微环境中的机械相互作用.

主要成果:

E26转化特异性1 (ETS1) 是EM中一个关键的转录调节器.
在子宫内膜异位症病变中,特别是卵巢内膜瘤中,ETS1表达显著升高.
ETS1主要表达在内皮细胞中,并与增强的血管新生活性有关.
在ETS1上调节VEGFR1和VEGFR2,放大VEGF信号.
巨细胞衍生的VEGFA是ETS1.1的主要上游激活剂.

结论:

VEGF-ETS1轴是子宫内膜异位症病理性血管生成的核心驱动因素.
ETS1是一种与子宫内膜异位症相关的血管改造的机械特征.
ETS1代表了对子宫内膜异位症的有前途的治疗点.

关键词:

血管新生的产生.在ETS1中,ETS1是ETS1.子宫内膜异位症是什么?子宫内膜异位症是什么?内皮细胞是内皮细胞.单细胞RNA测序的一个细胞.文字转录学 (Transcriptomics) 是一个学科.在VEGF中,VEGF是VEGF.在VEGF-ETS1轴上

更多相关视频

Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling

Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling

Published on: August 3, 2018

Author Spotlight: Investigating Angiogenesis and Vessel Permeability Through a Modified Matrix Gel Plug Assay

Author Spotlight: Investigating Angiogenesis and Vessel Permeability Through a Modified Matrix Gel Plug Assay

Published on: June 30, 2023

相关概念视频

Regulation of Angiogenesis and Blood Supply

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...

Mechanism of Angiogenesis

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...